Purpose To construct a venous thromboembolism(VTE) risk prediction model for postoperative patients with esophageal cancer. Methods Convenience sampling was used to select 220 patients who underwent esophageal cancer surgery in a tertiary grade-A hospital from January 2020 to April 2022 as the modeling group, with 60 in the VTE group and 160 in the non-VTE group. Logistic regression analysis was used to establish the VTE risk prediction model, which was validated by a separate validation group. Results Risk factors for postoperative VTE in patients with esophageal cancer included age ≥60 years, comorbidities, neoadjuvant chemotherapy (NACT), operative duration, postoperative use of prothrombin complex concentrates (PCC), and postoperative D-D at 12 hours. The model showed good predictive accuracy. In the modeling group, HL test showed P=0.250, area under receiver operating characteristic curve(AUC) was 0.766, the best cutoff value was 0.445, the sensitivity was 0.783, the specificity was 0.662. In the validation group, AUC was 0.738, the sensitivity was 0.682, the specificity was 0.769, the prediction accuracy was 80%. Conclusion The prediction model has demonstrated good predictive performance and can provide reference for assessing VTE risk in postoperative patients with esophageal cancer.
CAO Juan
,
LI Fang
,
YU Yue
,
DAI Li
,
YANG Dan-dan
,
LI Zhi-hua
,
XU Xin-yi
,
DAI Qi
,
CHEN Ke-yu
. Construction and verification of risk prediction model for venous thromboembolism after esophageal cancer surgery[J]. Journal of Nursing, 2024
, 31(8)
: 63
-68
.
DOI: 10.16460/j.issn1008-9969.2024.08.063
[1] World Health Organization.Global cancer observatory: cancerToday[EB/OL].[2023-04-30].https://gco.iarc.fr/today.
[2] Adiamah A, Ban L, West J, et al. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy:a population-based cohort study[J]. Dis Esophagus,2020,33(6):doz079. DOI:10.1093/dote/doz079.
[3] Hata T, Ikeda M, Miyata H, et al.Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese National Clinical Database (516217 cases)[J]. Ann Gastroenterol Surg,2019,3(5):534-543. DOI:10.1002/ags3.12275.
[4] Mulder FI, Hovenkamp A, van Laarhoven HWM, et al. Thromboembolic and bleeding complications in patients with oesophageal cancer[J]. Br J Surg, 2020,107(10):1324-1333. DOI: 10.1002/bjs.11665.
[5] 中国胸外科静脉血栓栓塞症研究组.中国胸部恶性肿瘤围手术期静脉血栓栓塞症预防与管理指南(2022版)[J].中华外科杂志,2022, 60(8):721-731.DOI:10.3760/cma.j.cn112139-20220430-00194.
[6] 张鑫,骆宝建,韩芬,等.肺癌胸腔镜术后静脉血栓栓塞发生的危险因素及预测模型的构建[J].中国医药,2022,17(10):1477-1481.DOI:10.3760/j.issn.1673-4777.2022.10.009.
[7] 侯铃宇. 肺癌患者并发静脉血栓栓塞症危险因素分析及风险预测模型的研究[D].南昌:南昌大学医学部,2022.
[8] 褚玲玲,陈萍,冯丹,等. 肿瘤相关静脉血栓栓塞症防治指南的质量评价及内容分析[J].护理学报,2022,29(16):43-48. DOI:10.16460/j.issn1008-9969.2022.16.043.
[9] Mulder FI, Hovenkamp A, van Laarhoven HWM, et al. Thromboembolic and bleeding complications in patients with oesophageal cancer[J]. Br J Surg, 2020, 107(10):1324-1333. DOI: 10.1002/bjs.11665.
[10] Drebes A, de Vos M, Gill S, et al. Prothrombin complex concentrates for coagulopathy in liver disease: single-center, clinical experience in 105 patients[J]. Hepatol Commun, 2019, 3(4):513-524. DOI:10.1002/hep4.1293.
[11] Ghosh S, Krege W, Doerr B, et al.Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models[J]. PLoS One, 2021, 16(10):e0258192.DOI:10.1371/journal.pone.0258192. eCollection 2021.
[12] ritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: advances in diagnosis and treatment[J]. JAMA,2018,320(15):1583-1594.DOI:10.1001/jama.2018.14346.
[13] Ke L, Cui S, Chen S, et al.Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism[J].Thorac Cancer, 2020,11(9):2483-2492. DOI:10.1111/1759-7714.13559.
[14] Lutsey PL, Zakai NA.Epidemiology and prevention of venous thromboembolism[J]. Nat Rev Cardiol, 2023, 20(4):248-262. DOI:10.1038/s41569-022-00787-6.
[15] Gregson J, Kaptoge S, Bolton T, et al.Cardiovascular risk factors associated with venous thromboembolism[J]. JAMA Cardiol, 2019, 4(2):163-173. DOI:10.1001/jamacardio.2018.4537.
[16] 陈颖,秦贤,孙乔,等.危重症患者下肢深静脉血栓风险预测模型的构建及评价[J]. 护理学杂志, 2021, 36(6):35-38.DOI:10.3870/j.issn.1001-4152.2021.06.035.
[17] 宁伟超,李贤. 外科手术后下肢深静脉血栓风险预测模型[J]. 护理研究, 2022, 36(12):2113-2118.DOI:10.12102/j.issn.1009-6493.2022.12.008.
[18] 柳思华,赵清,何鑫,等.北京协和医院外科老年患者术后静脉血栓栓塞症流行病学调查[J]. 中华老年多器官疾病杂志,2021, 20(11):817-822.DOI:10.11915/j.issn.1671-5403.2021.11.171.
[19] Kim JY, Khavanin N, Rambachan A, et al.Surgical duration and risk of venous thromboembolism[J]. JAMA Surg,2015,150(2):110-117. DOI:10.1001/jamasurg.2014.1841.
